Xerosis Market Research Report- Global Forecast till 2030

Xerosis market information: by Treatment (emollients, moisturizer, humidifier, oils, others) by Causes (eczema, psoriasis, diabetes, hypothyroidism, aging, others) by End Users (hospitals, dermatology clinics, home care) - Global Forecast till 2030

ID: MRFR/Pharma/2722-HCR | 90 Pages | Published By Kinjoll Dey on April 2023         

Xerosis Market Speak to Analyst Request a Free Sample

Market Synopsis of Xerosis market:

The Xerosis market is expected to reach USD 12,273.4 Million by 2030 at 8.2% CAGR during the forecast period 2022-2030.

Xerosis also known as xeroderma is a condition characterised by excessive dry skin caused by over cleansing, excessive showers, living in areas of low humidity, dehydration, extended exposure to sun, ageing etc. Xerosis commonly affects the scalp, lower legs, arms and thighs with symptoms such as scaling which is the visible peeling of the outer skin layer, itching, and skin cracking. Other symptoms are dry, itchy, and scaly skin, flaky skin, irritated red skin etc. Xerosis is common in the winter due to cold dry air causing the skin to lose moisture. Xerosis can also be caused by a deficiency of vitamin A, vitamin D, due to systemic illness and side effects associated with medication. The standard treatment of Xerosis is application of emollients, moisturizers etc. 

Xerosis also responds well to lifestyle changes. Hormonal changes due to ageing, diabetes etc. affect the sweat glands and sebaceous glands which increases the chances of Xerosis. The application of highly occlusive barriers to skin such as petrolatum, vegetable oils, mineral oil etc. provides excellent results. Lanolin, a natural lipid derived from sheep's wool, provides replacement of the natural lipids in human skin and is one of the most effective treatments for xeroderma. The main drawback of lanolin is that it is a common allergen and that it is a thick waxy substance that is difficult and inconvenient for use.

Xerosis market is driven by factors such as growing awareness, influence of lifestyle and fashion industry, increasing cases of skin dryness due to increasing pollution etc. Xerosis market constraints are huge number of low quality players which have fragmented the market, self-correcting nature of Xerosis etc. There is also a huge ambiguity regarding the claims of many products which is a threat to the future market. Pressure to reduce cost due to cut throat competition has forced many players especially those operating from poor regions to substitute high cost materials with lower ones often compromising on quality which has reduced the credibility of the Xerosis market for quality manufacturers. Thus the returns on advertisement are believed to fall in the future.

 Xerosis Market Share

Sources: Mayo Clinic, MRFR Analysis.

Key players of Xerosis market: Procter & Gamble, Alba Botanica, Avalon Organics, Johnson & Johnson Consumer Inc., Galderma Laboratories, Clarins, Unilever, Hempz, L’Oréal, Avon, Croda International Plc, Beiersdorf, Estee Lauder, United-Guardian, Inc., Dow Corning Corp. and others. Segments: Global xerosis market is segmented on the basis of treatment, causes and end users. Based on treatment, the market has been segmented as emollients, moisturizer, humidifier, oils and others. Based on the causes, the market has been segmented as eczema, psoriasis, diabetes, hypothyroidism, aging, and others. Based on the end users, the market has been segmented as hospitals, dermatology clinics and home care. Figure 1   Xerosis Market by End Users, 2016 (% Market Share)

Xerosis Market Outlook 

Regional analysis

US accounts for the maximum Xerosis market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the Xerosis market. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate Xerosis market growth due to poor economic and political conditions and poor healthcare penetration. The report for Global Xerosis market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Intended Audience

  • Global Xerosis manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

xerosis market is projected to grow at a 8.2% CAGR between 2022-2030.

The US is expected to dominate the xerosis market.

xerosis market is predicted to touch USD 12,273.4 Million by 2030.

Major end users of the xerosis market include home care, dermatology clinics, and hospitals.

Key players profiled in the xerosis market include Dow Corning Corp., United-Guardian, Inc., Estee Lauder, Beiersdorf, Croda International Plc, Avon, L’Oréal, Hempz, Unilever, Clarins, Galderma Laboratories, Johnson & Johnson Consumer Inc., Avalon Organics, Alba Botanica, and Procter & Gamble.